Get started
Author

Takeshi Imaoka

Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial
2022 · Nobuya Inagaki, Masakazu Takeuchi, et al. · The Lancet Diabetes & Endocrinology · 235
Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial
2022 · Takashi Kadowaki, Rina Chin, et al. · The Lancet Diabetes & Endocrinology · 135
Once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide is non‐inferior to once‐daily liraglutide and superior to placebo in J apanese patients with type 2 diabetes: a 26‐week randomized phase III study
2015 · J. Miyagawa, M. Odawara, et al. · Diabetes Obesity and Metabolism · 98
PDF
Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized placebo‐ and tamsulosin‐controlled 12‐week study in A sian men
2012 · Osamu Yokoyama, Masaki Yoshida, et al. · International Journal of Urology · 86
Efficacy and Safety Profile of Exenatide Once Weekly Compared With Insulin Once Daily in Japanese Patients With Type 2 Diabetes Treated With Oral Antidiabetes Drug(s): Results From a 26-Week, Randomized, Open-Label, Parallel-Group, Multicenter, Noninferiority Study
2012 · Nobuya Inagaki, Yoshihito Atsumi, et al. · Clinical Therapeutics · 84
Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in J apanese patients with type 2 diabetes: a randomized, open‐label, phase III , non‐inferiority study
2015 · E. Araki, N. Inagaki, et al. · Diabetes Obesity and Metabolism · 82
PDF
A phase 1 multiple‐ascending dose study of tirzepatide in Japanese participants with type 2 diabetes
2021 · Kenichi Furihata, Hanaka Mimura, et al. · Diabetes Obesity and Metabolism · 62
PDF
Once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once‐daily liraglutide in J apanese patients with type 2 diabetes: 52 weeks of treatment in a randomized phase III study
2015 · M. Odawara, J. Miyagawa, et al. · Diabetes Obesity and Metabolism · 58
PDF
Improved glycemic control and reduced bodyweight with exenatide: A double-blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24 weeks
2010 · Takashi Kadowaki, Mitsuyoshi Namba, et al. · Journal of Diabetes Investigation · 51
PDF
Monotherapy with the once weekly GLP-1 receptor agonist dulaglutide for 12 weeks in Japanese patients with type 2 diabetes: dose-dependent effects on glycaemic control in a randomised, double-blind, placebo-controlled study
2014 · Yasuo Terauchi, Yoichi Satoi, et al. · Endocrine Journal · 50
PDF
Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone
2003 · Satoru Nakai, Tsuyoshi Hirose, et al. · European Journal of Pharmacology · 44
Tadalafil for the Treatment of Lower Urinary Tract Symptoms in Japanese Men with Benign Prostatic Hyperplasia: Results from a 12‐week Placebo‐controlled Dose‐finding Study with a 42‐week Open‐label Extension
2012 · Masayuki TAKEDA, Osamu NISHIZAWA, et al. · LUTS Lower Urinary Tract Symptoms · 39
Evaluation of Routine Sonography for Early Detection of Pancreatic Cancer
1996 · S. Tanaka, T. Kitamra, et al. · Japanese Journal of Clinical Oncology · 37
Effects of the Plasma Concentration of 5‐Fluorouracil and the Duration of Continuous Venous Infusion of 5‐Fluorouracil with an Inhibitor of 5‐Fluorouracil Degradation on Yoshida Sarcomas in Rats
1989 · Setsuro Fujii, Yuji Shimamoto, et al. · Japanese Journal of Cancer Research · 32
Safety and efficacy analyses across age and body mass index subgroups in East Asian participants with type 2 diabetes in the phase 3 tirzepatide studies ( SURPASS programme)
2022 · Arihiro Kiyosue, Julia P. Dunn, et al. · Diabetes Obesity and Metabolism · 30
PDF
A 1-year safety study of dulaglutide in Japanese patients with type 2 diabetes on a single oral hypoglycemic agent: an open-label, nonrandomized, phase 3 trial
2015 · Masanori Emoto, Yasuo Terauchi, et al. · Endocrine Journal · 29
PDF
Antitumor Activity of BOF‐A2, a New 5‐Fluorouracil Derivative
1989 · Setsuro Fujii, Masakazu Fukushima, et al. · Japanese Journal of Cancer Research · 25
3-Cyano-2, 6-Dihydroxypyridine (CNDP), a New Potent Inhibitor of Dihydrouracil Dehydrogenase
1993 · Kunihiko Tatsumi, Takeshi Yamauchi, et al. · The Journal of Biochemistry · 23
Postextrasystolic contractile decay always contains exponential and alternans components in canine heart
2000 · Juichiro Shimizu, Junichi Araki, et al. · American Journal of Physiology-Heart and Circulatory Physiology · 21
Glucagon-Like Peptide-1 Receptor Agonist Utilization in Type 2 Diabetes in Japan: A Retrospective Database Analysis (JDDM 57)
2020 · Yasushi Ishigaki, Alena Strizek, et al. · Diabetes Therapy · 20
PDF
Effects of insulin changes on quality of life and glycemic control in J apanese patients with type 2 diabetes mellitus: The insulin‐changing study intending to gain patients' insights into insulin treatment with patient‐reported health outcomes in actual clinical treatments ( INSIGHT s) study
2013 · Hitoshi Ishii, Yasuo Terauchi, et al. · Journal of Diabetes Investigation · 16
PDF
Energy-wasteful total Ca2+handling underlies increased O2cost of contractility in canine stunned heart
2000 · Shinyu Lee, Junichi Araki, et al. · American Journal of Physiology-Heart and Circulatory Physiology · 15
Logistic Time Constant of Isometric Relaxation Force Curve of Ferret Ventricular Papillary Muscle. Reliable Index of Lusitropism.
2000 · Ju Mizuno, Junichi Araki, et al. · The Japanese Journal of Physiology · 15
PDF
Safety of exenatide once weekly for 52 weeks in J apanese patients with type 2 diabetes mellitus
2012 · Yukiko Onishi, Hiroyuki Koshiyama, et al. · Journal of Diabetes Investigation · 14
PDF
Long-term safety and efficacy of exenatide twice daily in Japanese patients with suboptimally controlled type 2 diabetes
2011 · Nobuya Inagaki, Kohjiro Ueki, et al. · Journal of Diabetes Investigation · 13
PDF
Works count: 82
Citation count: 1,450
H-index: 20
I10-index: 29
Year
Topic
Type